Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma...
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024
About this item
Full title
Author / Creator
Oizumi, Satoshi , Takamura, Kei , Harada, Toshiyuki , Tachihara, Motoko , Morikawa, Naoto , Honda, Ryoichi , Watanabe, Satoshi , Asao, Tetsuhiko , Kunisaki, Mamoru , Fukuhara, Tatsuro , Noro, Rintaro , Kikuchi, Eiki , Tsutani, Yasuhiro , Tenma, Toshiyuki , Kobayashi, Kunihiko , Dosaka-Akita, Hirotoshi and North East Japan Study Group, Hokkaido Lung Cancer Clinical Study Group
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Objectives
Only a few prospective studies have been conducted to examine the efficacy and safety of systemic chemotherapy for patients with pulmonary sarcomatoid carcinomas (PSCs). There is, thus, a crucial need to develop novel treatment strategies for this rare tumor.
Patients and methods
Chemotherapy-naïve patients with histologically c...
Alternative Titles
Full title
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024
Authors, Artists and Contributors
Author / Creator
Takamura, Kei
Harada, Toshiyuki
Tachihara, Motoko
Morikawa, Naoto
Honda, Ryoichi
Watanabe, Satoshi
Asao, Tetsuhiko
Kunisaki, Mamoru
Fukuhara, Tatsuro
Noro, Rintaro
Kikuchi, Eiki
Tsutani, Yasuhiro
Tenma, Toshiyuki
Kobayashi, Kunihiko
Dosaka-Akita, Hirotoshi
North East Japan Study Group, Hokkaido Lung Cancer Clinical Study Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2623889878
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2623889878
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-021-02113-5
